Clinical Laboratory Tests Market Overview
Healthcare systems around the world are increasingly focusing on clinical efficacy and effectiveness in order to achieve the fundamental goals of medical laboratory testing. The ultimate goal is to provide timely and high-quality care to patients, moving the clinical laboratory testing market forward. Healthcare laboratory test results have affected 60–70% of clinical decisions in developed countries, which is unsurprising. Several of these tests were prompted by regulatory requirements.
A key pillar of high-quality patient care has always been the need for high-quality diagnostic testing. This drive is the major driver behind the market for clinical laboratory tests. The demand has grown as the incidence of chronic diseases has increased, as has the morbidity of noncommunicable diseases.
Increased access to disease-specific diagnostic and confirmatory testing has become a source of concern for both private and public health systems. As a result, they have increased their spending on clinical lab infrastructure upgrades. In developing economies, hospitals have placed a premium on the comfort and convenience of their patients, ensuring that reliable infrastructure is available locally. The focus has given a significant boost to the growth of the clinical laboratory tests market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, End-use, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Genoptix, Inc. (Novartis AG), Eurofins Scientific, ARUP Laboratories, UNILABS, Genomic Health, Inc., SYNLAB International GmbH, NeoGenomics Laboratories, Inc., Sonic Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc. |
Covid-19 Impact on Clinical Laboratory Tests Market
In addition, the current Clinical Laboratory Tests Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Clinical Laboratory Tests Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Clinical Laboratory Tests Market Segment Overview
Based on Type, Basic Metabolic Tests accounted for a major portion of the global market for clinical laboratory tests. This is because of the rising prevalence of lifestyle-related disorders such as metabolic abnormalities and obesity. Furthermore, due to rising awareness of the incidence of cardiovascular disorders and diabetes, lipid panel tests are expected to be the fastest-growing segment over the forecast period.
Clinical Laboratory Tests Market, By Type
· Complete Blood Count
· HGB/HCT
· Basic Metabolic Panel
· BUN Creatinine Tests
· Renal Panel
· Lipid Panel
· Others
Clinical Laboratory Tests Market, By End-use
· Central Laboratories
· Primary Clinics
Clinical Laboratory Tests Market Regional Overview
Region-Wise, the global market for clinical laboratory testing dominated by North America. The regional market's dominance is bolstered by the rising use of improved diagnostic techniques and rising test volumes. Moreover, due to improvements in healthcare infrastructure enabling the introduction of advanced diagnostic technologies in emerging regions such as China and India, Asia Pacific is expected to be the fastest-growing market throughout the forecast period. Furthermore, the presence of untapped potential in the form of unmet medical demands, favourable economic growth, and expanding scientific research avenues are some of the key drivers for the Asia Pacific clinical laboratory tests market.
Clinical Laboratory Tests Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Clinical Laboratory Tests Market, Key Players
· Genoptix, Inc. (Novartis AG)
· Eurofins Scientific
· ARUP Laboratories
· UNILABS
· Genomic Health, Inc.
· SYNLAB International GmbH
· NeoGenomics Laboratories, Inc.
· Sonic Healthcare
· Quest Diagnostics Incorporated
· Laboratory Corporation of America Holdings
· Charles River Laboratories International, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Clinical Laboratory Tests market?
A key pillar of high-quality patient care has always been the need for high-quality diagnostic testing. This drive is the major driver behind the market for clinical laboratory tests
Q2. Which Segments are covered in the global Clinical Laboratory Tests market report?
Type, End-use, and Region. these segments are covered in the global Clinical Laboratory Tests market report.
Q3. Which segment is projected to hold the largest share in the global Clinical Laboratory Tests market?
Basic Metabolic Tests segment is projected to hold the largest share in the global Clinical Laboratory Tests market.
Q4. Which region holds the largest share in the global Clinical Laboratory Tests market?
North America holds the largest share in the global Clinical Laboratory Tests market
Q5. Which are the prominent players in the global Clinical Laboratory Tests market?
Genoptix, Inc. (Novartis AG), Eurofins Scientific, ARUP Laboratories, UNILABS, Genomic Health, Inc., SYNLAB International GmbH, NeoGenomics Laboratories, Inc., Sonic Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc. are some key players in the global Clinical Laboratory Tests market
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Clinical Laboratory Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Complete Blood Count
- 5.2.2. HGB/HCT
- 5.2.3. Basic Metabolic Panel
- 5.2.4. BUN Creatinine Tests
- 5.2.5. Renal Panel
- 5.2.6. Lipid Panel
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast – By End-use
- 5.3.1. Central Laboratories
- 5.3.2. Primary Clinics
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Clinical Laboratory Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Complete Blood Count
- 6.2.2. HGB/HCT
- 6.2.3. Basic Metabolic Panel
- 6.2.4. BUN Creatinine Tests
- 6.2.5. Renal Panel
- 6.2.6. Lipid Panel
- 6.2.7. Others
- 6.3. Market Analysis, Insights and Forecast – By End-use
- 6.3.1. Central Laboratories
- 6.3.2. Primary Clinics
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Clinical Laboratory Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Complete Blood Count
- 7.2.2. HGB/HCT
- 7.2.3. Basic Metabolic Panel
- 7.2.4. BUN Creatinine Tests
- 7.2.5. Renal Panel
- 7.2.6. Lipid Panel
- 7.2.7. Others
- 7.3. Market Analysis, Insights and Forecast – By End-use
- 7.3.1. Central Laboratories
- 7.3.2. Primary Clinics
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Clinical Laboratory Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Complete Blood Count
- 8.2.2. HGB/HCT
- 8.2.3. Basic Metabolic Panel
- 8.2.4. BUN Creatinine Tests
- 8.2.5. Renal Panel
- 8.2.6. Lipid Panel
- 8.2.7. Others
- 8.3. Market Analysis, Insights and Forecast – By End-use
- 8.3.1. Central Laboratories
- 8.3.2. Primary Clinics
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Clinical Laboratory Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Complete Blood Count
- 9.2.2. HGB/HCT
- 9.2.3. Basic Metabolic Panel
- 9.2.4. BUN Creatinine Tests
- 9.2.5. Renal Panel
- 9.2.6. Lipid Panel
- 9.2.7. Others
- 9.3. Market Analysis, Insights and Forecast – By End-use
- 9.3.1. Central Laboratories
- 9.3.2. Primary Clinics
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Genoptix, Inc. (Novartis AG)
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Eurofins Scientific
- 10.6. ARUP Laboratories
- 10.7. UNILABS
- 10.8. Genomic Health, Inc.
- 10.9. SYNLAB International GmbH
- 10.10. NeoGenomics Laboratories, Inc.
- 10.11. Sonic Healthcare
- 10.12. Quest Diagnostics Incorporated
- 10.13. Laboratory Corporation of America Holdings
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
